TargetMol

Rosaprostol

Product Code:
 
TAR-T24728
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24728-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24728-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24728-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Rosaprostol is an agent of the anti-ulcer drug.
CAS:
56695-65-9
Formula:
C18H34O2
Molecular Weight:
282.468
Purity:
0.98
SMILES:
CCCCCCC1CCCC1CCCCCCC(O)=O

References

1. ?ukasik B, Perlikowska W, ?urawi?ski R, Miko?ajczyk M. Synthesis of Enantiomerically Pure Stereomers of Rosaprostol. J Org Chem. 2015 Oct 2;80(19):9798-802. doi: 10.1021/acs.joc.5b01749. PubMed PMID: 26355965. 2. Segre G, Fiaschi AI, Bianchi E, Ciani D, Tedeschi S. Serum and urine kinetics of rosaprostol in volunteers. Arzneimittelforschung. 1988 Dec;38(12):1846-9. PubMed PMID: 3245860. 3. Perlikowska W, ?urawi?ski R, Miko?ajczyk M. A new and expeditious synthesis of all enantiomerically pure stereoisomers of rosaprostol, an antiulcer drug. Beilstein J Org Chem. 2016 Oct 21;12:2234-2239. eCollection 2016. PubMed PMID: 27829932; PubMed Central PMCID: PMC5082602. 4. Tincani GP, Maniscalco G, Gunelli M, Ciarrocchi V. [Treatment of duodenal ulcer with rosaprostol in patients resistant to treatment with anti-H2]. Minerva Med. 1987 Jun 30;78(12):847-53. Italian. PubMed PMID: 2885786.